Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose study of ciprofol combined with oliceridine fumarate for painless hysteroscopy
ChiCTR2400091853Phase 4Not yet recruiting
- Sponsor
- The Affiliated Shunde Hospital of Jinan University
- Start
- Nov 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and oliceridine in procedural discomfort (3 arms), sponsored by The Affiliated Shunde Hospital of Jinan University. Primary endpoint: Dose of ciprofol per patient for positive or negative response. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ciprofololiceridine
03
Conditions
procedural discomfort
Beyond the preview
Go deeper on ChiCTR2400091853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091853.